Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Viridian Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 135
- +13 vs. Q4 2022
- Shares held
- 43.1M
- +1.83M (+4.4%) vs. Q4 2022
- Total value
- $1.10B
- −$110.3M (−9.1%) vs. Q4 2022
- New holders
- 28
- 54 more added
- Sold out
- 15
- 37 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 254,821 | $6.48M | 0.00% | +139,443+120.9% | Added |
| 5AM Venture Management, LLC | 280,000 | $7.12M | 1.82% | −20,000−6.7% | Reduced |
| Fred Alger Management, LLC | 323,676 | $8.23M | 0.04% | −104,597−24.4% | Reduced |
| Goldman Sachs Group Inc | 354,910 | $9.03M | 0.00% | +111,236+45.6% | Added |
| Northern Trust Corp | 370,926 | $9.44M | 0.00% | +9,237+2.6% | Added |
| Driehaus Capital Management LLC | 406,777 | $10.3M | 0.15% | −37,555−8.5% | Reduced |
| Morgan Stanley | 433,134 | $11.0M | 0.00% | +97,832+29.2% | Added |
| Eagle Asset Management Inc | 461,665 | $11.7M | 0.07% | +461,665 | New |
| Artal Group S.A. | 504,978 | $12.8M | 0.76% | +504,978 | New |
| Kynam Capital Management, LP | 543,603 | $13.8M | 1.79% | −491,094−47.5% | Reduced |
| Polar Capital Holdings Plc | 550,000 | $14.0M | 0.10% | +550,000 | New |
| Hood River Capital Management LLC | 566,498 | $14.4M | 0.47% | +566,498 | New |
| Nuveen Asset Management, LLC | 577,627 | $14.7M | 0.01% | +256,161+79.7% | Added |
| Millennium Management LLC | 614,089 | $15.6M | 0.02% | −171,765−21.9% | Reduced |
| Marshall Wace, LLP | 629,320 | $16.0M | 0.04% | +17,863+2.9% | Added |
| TCG Crossover Management, LLC | 663,610 | $16.9M | 3.29% | −320,000−32.5% | Reduced |
| Tang Capital Management LLC | 692,925 | $17.6M | 2.63% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 776,112 | $19.7M | 0.00% | +65,127+9.2% | Added |
| Cormorant Asset Management, LP | 850,000 | $21.6M | 1.42% | −250,000−22.7% | Reduced |
| Logos Global Management LP | 950,000 | $24.2M | 3.46% | −50,000−5.0% | Reduced |
| Pictet Asset Management SA | 1,042,965 | $26.5M | 0.03% | +1,042,965 | New |
| Octagon Capital Advisors LP | 1,185,000 | $30.1M | 4.35% | +360,800+43.8% | Added |
| Yiheng Capital Management, L.P. | 1,228,534 | $31.3M | 2.44% | +265,278+27.5% | Added |
| Deep Track Capital, LP | 1,230,259 | $31.3M | 1.33% | −540,895−30.5% | Reduced |
| Alliancebernstein L.P. | 1,244,150 | $31.7M | 0.01% | +320,317+34.7% | Added |
| Fairmount Funds Management LLC | 1,369,623 | $34.8M | 5.99% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,678,207 | $42.7M | 3.19% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 1,736,386 | $44.2M | 1.31% | +515,811+42.3% | Added |
| Ra Capital Management, L.P. | 2,007,946 | $51.1M | 1.16% | +1,127,946+128.2% | Added |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53.1M | 5.03% | +334,531+19.1% | Added |
| Vanguard Group Inc | 2,130,233 | $54.2M | 0.00% | +15,239+0.7% | Added |
| Commodore Capital LP | 2,189,659 | $55.7M | 8.48% | +169,493+8.4% | Added |
| State Street Corp | 2,401,812 | $61.1M | 0.00% | +538,622+28.9% | Added |
| VR Adviser, LLC | 2,699,865 | $68.7M | 13.41% | 00.0% | Unchanged |
| BlackRock Inc. | 2,773,386 | $70.6M | 0.00% | +11,830+0.4% | Added |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −338,167−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −313,403−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −304,552−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −267,765−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −204,600−100.0% | Sold out |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −35,887−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −35,003−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −31,400−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −27,915−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −25,769−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −17,974−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,207−100.0% | Sold out |
| Kula Investments, LLC | 0 | $0 | 0.00% | −10,580−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −8,086−100.0% | Sold out |